Public Health News Roundup: August 13
EBOLA UPDATE: Canada to Donate Experimental Drug for Ebola Treatment
(NewPublicHealth is monitoring the public health crisis in West Africa.)
Canada announced late yesterday that it will donate 800 to 1,000 doses of its experimental Ebola vaccine for the World Health Organization (WHO) to use in West Africa. WHO declared yesterday that it was ethical to use untested drugs to combat the Ebola outbreak. "We see this as a global resource, something we need to put on the global table to say...how can we make best use of this asset? We're looking to do that as fast as we can,” said Greg Taylor, MD, deputy chief public health officer of the Public Health Agency of Canada, according to Reuters. Read more on Ebola.
CDC: 40 Percent of Americans Will Develop Diabetes
An estimated 40 percent of Americans will develop diabetes at some point in their lives, according to a new study in The Lancet Diabetes & Endocrinology. Researchers from the U.S. Centers for Disease Control and Prevention analyzed data on 598,216 adults from 1985 to 2011, finding that the increase in the diagnosis of diabetes and overall declining mortality means that people are also living longer with diabetes; years spent with diabetes increased by 156 percent in men and 70 percent in women. Researchers said the findings demonstrate a need for effective interventions to reduce the incidence of diabetes. Read more on diabetes.
FDA Approves Device that Could Increase the Number of Transplantable Lungs
The U.S. Food and Drug Administration (FDA) has approved a new device to preserve donated lungs that do not initially meet the standards for transplantation, but that might be transplantable given more time to evaluate their viability. Only approximately one in five donated lungs meet transplantation criteria. There were 1,754 lung transplants in the United States in 2012, with 1,616 potential patients remaining on the recipient list at the end of the year. “This innovative device addresses a critical public health need,” said Christy Foreman, director of the Office of Device Evaluation at the FDA’s Center for Devices and Radiological Health. “With this approval, there may be more lungs available for transplant, which could allow more people with end stage lung disease who have exhausted all other treatment options to be able to receive a lung transplant.” Read more on technology.